Figure 3.
Figure 3. Expression of Runx1 in hematopoietic lineages. The filled and open curves indicate GFP expression in wild-type and Runx1-IRES-GFPk/k cells, respectively. (A) Analysis of GFP expression in cell populations enriched for HSC activity. Bone marrow cells prepared from Runx1-IRES-GFPk/k and wild-type mice were stained for c-kit using an APC-conjugated antibody and an array of lineage-associated markers using a cocktail of biotinylated antibodies (CD4, CD8, B220, GR-1, Mac1, and Ter119), with the latter revealed by SA-PE staining. The gating strategy is depicted in the dot plot, and panels i and ii show the expression of Runx1-GFP in c-kit-lin- and c-kit+lin- cells, respectively. The MFI of the indicated population is shown in the panel. (B) Bone marrow cells were prepared from Runx1-IRES-GFPk/k and wild-type mice, stained for Ter-119 and c-kit, and GFP expression in c-kit+Ter-119+ and c-kit-Ter-119+ fractions was determined by flow cytometry. (C) MEL cells were treated for the indicated time with 1.6% DMSO to induce erythroid differentiation. Expression of Runx1 was determined by Western blot analysis using a Runx1-specific antibody; expression of Herf1, an erythroid-specific protein, was also determined to confirm erythroid differentiation.

Expression of Runx1 in hematopoietic lineages. The filled and open curves indicate GFP expression in wild-type and Runx1-IRES-GFPk/k cells, respectively. (A) Analysis of GFP expression in cell populations enriched for HSC activity. Bone marrow cells prepared from Runx1-IRES-GFPk/k and wild-type mice were stained for c-kit using an APC-conjugated antibody and an array of lineage-associated markers using a cocktail of biotinylated antibodies (CD4, CD8, B220, GR-1, Mac1, and Ter119), with the latter revealed by SA-PE staining. The gating strategy is depicted in the dot plot, and panels i and ii show the expression of Runx1-GFP in c-kit-lin- and c-kit+lin- cells, respectively. The MFI of the indicated population is shown in the panel. (B) Bone marrow cells were prepared from Runx1-IRES-GFPk/k and wild-type mice, stained for Ter-119 and c-kit, and GFP expression in c-kit+Ter-119+ and c-kit-Ter-119+ fractions was determined by flow cytometry. (C) MEL cells were treated for the indicated time with 1.6% DMSO to induce erythroid differentiation. Expression of Runx1 was determined by Western blot analysis using a Runx1-specific antibody; expression of Herf1, an erythroid-specific protein, was also determined to confirm erythroid differentiation.

Close Modal

or Create an Account

Close Modal
Close Modal